[Results and prospects of using thymosin for the purpose of regulating the immune system in different pathological processes and states].
D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy; D004306:Dose-Response Relationship, Immunologic; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D007111:Immunity, Cellular / Q000187:drug effects; D007114:Immunization; D007121:Immunocompetence / Q000187:drug effects; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy; D066298:In Vitro Techniques; D008970:Molecular Weight; D009374:Neoplasms, Experimental / Q000188:drug therapy; D013268:Stimulation, Chemical; D013947:Thymosin / Q000276:immunology / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*; D013997:Time Factors
D013951:Thymus Hormones; D013947:Thymosin
Rezul'taty i perspektivy primeneniia timozina s tsel'iu reguliatsii sistemy immuniteta pri razlichnykh patologicheskikh protsessakh i sostoianiiakh.